Strongbridge Biopharma plc (SBBP) Q2 2020 Earnings Conference Call August 4, 2020 8:30 AM ET Â Company Participants Lindsay Rocco - Elixir Health, Public Relations John Johnson - Chief Executive Officer Fred Cohen - Chief Medical Officer Rob Lutz - Chief Financial Officer Scott Wilhoit - Chief Commercial Officer Rich Kollender - Chief Operating Officer Conference Call Participants Chris Howerton - Jefferies Hartaj Singh - Oppenheimer and Company Avatar Jones - Stifel Jonathan Wolleben - JMP Securities Opera ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | | | | | Forward-looking statements 2 This document contains forward‐looking statements relating to the Company's strategy, objectives, business development plans and financial position. All statements other than statements of historical facts included in this document, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, status and results of cli ...

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Q1 2020 Earnings Conference Call May 7, 2020 8:30 AM ET Company Participants Allison Wey – Senior Vice President-Investor Relations and Corporate Communication Paul Edick – Chairman and Chief Executive Officer Barry Deutsch – Chief Financial Officer Conference Call Participants Randall Stanicky – RBC Capital Markets Dan Clark – Mizuho Securities David Amsellem – Piper Sandler Operator Ladies and gentlemen, thank you for standing by, and welcome to the Xeris Pharmace ...

| --- | --- | --- | |-------|-------|-------| | | | | | | | | | | | | | | | | Forward-looking statements 2 This document contains forward‐looking statements relating to the Company's strategy, objectives, business development plans and financial position. All statements other than statements of historical facts included in this document, including, without limitation, statements regarding the Company's future financial position, strategy, anticipated investments, costs and results, status and results of cli ...

Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) Q4 2019 Results Earnings Conference Call March 11, 2020 8:30 AM ET Company Participants Allison Wey - Senior Vice President of Investor Relations and Corporate Communications Paul Edick - Chairman & Chief Executive Officer Barry Deutsch - Chief Financial Officer Conference Call Participants Ami Fadia - Leerink Randall Stanicky - RBC Capital Markets David Amsellem - Piper Sandler Difei Yang - Mizuho Securities David Steinberg - Jefferies Operator Ladies and gentlemen ...